Roth CH V (NASDAQ:ROCL) announced this morning that it has slackened its grip on a possible deal with Slacker, allowing the letter of intent with the podcasting platform expire and breaking off further talks.
The two initially announced their LOI with a proposed enterprise value of $160 million in April and said at the time that the deal would hinge on how much capital the SPAC would be able to raise.
Roth CH V saw about 78% of its trust redeemed at an extension vote days after the LOI announcement, despite securing some shares with non-redemption pacts. That left it with about $25.9 million in its trust.
Slacker is a subsidiary of Los Angeles-based LiveOne (NASDAQ:LVO), which announced it expected to generate $51.7 million in revenue from its audio division last quarter of which Slacker accounted for $26 million. This was a profitable period with the division generating about $5 million in adjusted EBITDA.
This positive news may have also contributed to the parting of ways with Roth CH V. At the time the LOI was announced, LiveOne was struggling to cut costs, manage its debt and get itself to profitability. It had reported $74 million in total revenue in the nine months ending December 31, 2022, which was a decline from $93 million over the same period in 2021.
But, over this time it also managed to cut its net losses to -$4.6 million, down from -$35 million a year before. With a turnaround already in progress, LiveOne may not have still seen the need for a spinoff, or viewed it as favorably considering Slacker accounts for about half of its revenue.
Roth CH V plans to seek out an alternative deal and has until December 3 do complete one under its current deadline.
UY Scuti Acquisition Corp. (NASDAQ:UYSCU) announced the pricing of its $50 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “UYSCU”, Tuesday, April 1, 2025. The new SPAC aims to combine with a target company in Asia, but it does not have a specific preference on industry or...
April is set to be a less-eventful month for SPAC dealmakers seeing their shares unlocked, but the activity does start already tomorrow. The sponsor of Excelfin is set to see its promote shares in Baird Medical (NASDAQ:BDMD) come available to trade on April 1. It is one of just two sponsors being released this month...
At the SPAC of Dawn Two SPACs have scheduled shareholder votes for this week including Bukit Jalil 1‘s (NASDAQ:BUJA) special meeting to approve its combination with Global IBO Group later today. The SPAC still has about half of its $50 million trust in tact going into the vote and Global IBO’s core business of providing...
Terms Tracker for the Week Ending March 28, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. No SPAC IPOs priced this week, which means March closes out with just two IPOs total, both of which priced last week. By comparison, January...
At the SPAC of Dawn The year’s first big IPO has arrived, and its wings have already been trimmed before it got out the gate. AI chip firm CoreWeave had been aiming to price at a range of $47 to $55 per share, which would have valued the company at $26.5 billion at the top...